Jelli B, Taton O, D’Haene N, Remmelink M, Mekinda Z. Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma. EJCRIM 2021;8 doi:10.12890/2021_002749.